Micro Interventional Devices is developing disruptive technologies that are revolutionizing percutaneous and minimally invasive structural heart repair procedures. Our proprietary technology is based on a breakthrough in soft-tissue PolyCor™ anchoring and associated delivery devices that enable off-pump procedures.
Permaseal™ is a novel transapical access and closure device that combines soft-tissue PolyCor anchors with sutures to provide wound closure after structural heart repair procedures, such as transcatheter aortic valve replacement (TAVR) and the emerging transcatheter mitral valve replacement (TMVR) procedures.
MID acquired Endovalve, Inc. in April 2011. Endovalve™ is a mitral valve replacement technology. The proprietary PolyCor anchors are being incorporated into mitral repair and replacement technologies that MID has patented.
Permaseal and Endovalve™ will drive the revolution in access and closure and mitral valve replacement, respectively.
Please click on the “Products” Tab for more information.
CAUTION – Investigational Device Only. Limited by Federal (or United States) law to investigational use.
CAUTION. For Clinical Research ONLY. This device is NOT CE-marked and is to be used in Clinical Research Only.